The 70th American Academy of Neurology Annual Meeting (AAN) held in Los Angeles, California, from April 21 to April 27, 2018. The meeting delivered the latest developments in science, education, and networking in new and innovative ways.
The calcitonin gene-related peptide inhibitor lowered monthly migraine days by ≥50% in 30.3% of patients compared to 13.7% on placebo.
About the 70th American Academy of Neurology Annual Meeting:
The American Academy of Neurology represents more than 34,000 members and is committed to encouraging the highest quality patient-centered care. The 70th American Academy of Neurology Annual Meeting is the place to see and be seen in the world of neurology and is directed toward the world’s leading neurology experts. This year’s event delivered the latest developments in science and education, and those who attended the Los Angeles, California meeting gained valuable insight from some of the most respected leaders in the field. NeurologyLive offers those unable to attend with the most up-to-date information regarding existing treatment options, as well as data from clinical trials evaluating new and emerging therapies.
This NeurologyLive Conference Coverage page is a full-service resource center for the latest from the meeting, including key developments from research that may potentially lead to methods of early diagnosis, management, and prevention. This page features central coverage right from the floor and will offer visitors the chance to hear directly from those presenting this groundbreaking data.